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cannot be assessed by usual efﬁcacy and safety clinical endpoints.
Hence, the aim of the current evaluation was to compare the
perceived convenience of the once-weekly injection regimen of
Idraparinux (IDRA), with no need for monitoring, to usual VKA
treatment. METHODS: A total of 2556 patients with Atrial
Fibrillation, enrolled in an international randomized open-label
Phase III trial comparing IDRA to VKA, completed a self-
administered questionnaire assessing treatment convenience and
their satisfaction with it. The Perception AntiCoagulant Treat-
ment Questionnaire (PACT-Q) previously validated, measured
expectations (7 items) at baseline, treatment Convenience (13
items) and Satisfaction (7 items) both at 3 and 6 months (M3,
M6). Convenience and Satisfaction scores ranged from 0 (worst)
to 100 (best). Primarily IDRA was compared to VKA Conve-
nience scores at M3. Treatment comparisons (ANOVA) were
also performed on Satisfaction score, at M6 and with covariates
adjustment. RESULTS: Baseline expectations were comparable
between treatment groups. Mean Convenience scores at M3
were signiﬁcantly higher in IDRA than VKA (90.3 vs. 85.6,
p < 0.001). This result was maintained when adjusted for
country, age, gender, prior medication, and baseline expectations.
The better convenience of IDRA over VKA was conﬁrmed at M6.
Similar ﬁndings were shown on Satisfaction scores. CONCLU-
SION: Idraparinux was perceived as more convenient and satis-
factory than current standard VKA management by patients with
Atrial Fibrillation.
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OBJECTIVE: Evaluate the opinions of Canadian physicians
and patients towards adherence with cholesterol treatment.
METHODS: A convenience sample of 362 general practitioners
recruited across Canada completed a physician questionnaire. A
minimum of 20 statin patients per physician completed question-
naires during normally scheduled visits. An independent third
party collected and analyzed the data. Each physician received
aggregate practice level and entire patient cohort data.
RESULTS: A total of 13,508 patients participated; 42% of
cohort was 65 years or older. Reported medical conditions: 55%
high BP, 59% high LDL, 27% heart problems, 29% diabetes,
18% obesity, 6% stroke. Patient reasons for stopping statins:
26% don’t like taking medication, 20% needed more informa-
tion on side effects, 14% improved their diet or lost weight, 10%
needed more information on beneﬁts of statins. Physician opin-
ions on why patients have poor compliance to statins: 80%
resistance to taking medications, 68% side effects of medication,
64% lack understanding of the beneﬁts of statin therapy, 25%
achieved weight loss or diet improvements. Patient reported
factors that would motivate them to stay on therapy: 36% seeing
a printout of my levels, 32% knowing more about risks of high
cholesterol, 31% having the doctor discuss cholesterol in more
detail, 25% knowing more about my medication. Physician opin-
ions on key patient compliance motivators: 83% discussing cho-
lesterol issues with patients, 79% follow up discussion on levels,
72% discussing medications, 61% diet and lifestyle support
program. Medication change preference if not reaching LDL
target–patient vs. physician: Increase dose 51% vs. 75%, change
statin 40% vs. 7%, add another drug 9% vs. 19%. CONCLU-
SION: Differences exist in physician and patient reported reasons
for adherence to statin therapy. Understanding these differences
may assist physicians to counsel their patients more effectively
and possibly improve adherence.
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OBJECTIVE: To construct risk models linking psychological risk
factors with the risk of myocardial infarction (MI) and stroke.
METHODS: The Caerphilly Prospective Study (CaPS) comprises
a general population sample of 2959 men aged 45–59, followed
up for 20 years. Psychological Distress Indicator (PDI) was
constructed based on GHQ30; anxiety was measured with State
Trait Anxiety Questionnaire; type A behaviour with Jenkins
Activity Survey and Health Attitude Inventory; and anger with
four Framingham anger scales. Logistic, fractional polynomial
and Cox’s proportional hazards models were used to analyse the
data. A multivariate analysis that included standard and psycho-
logical risk factors was carried out. Composite indices based on
the sum of the main effects for the individual psychological risk
factors and main effects with interactions were developed.
RESULTS: In univariate analyses, no signiﬁcance was found for
psychological distress, anxiety, type A behaviour and anger mea-
sured on three scales for both MI and stroke. In men with low
anger-out scores, the odds ratio and hazard ratio of MI were
OR = 1.75 [95% CI: 1.25–2.43] and HR = 1.75 [95% CI: 1.28–
2.40], respectively, relative to men with high anger-out scores.
Cardiovascular risk explained by psychological factors increased
by up to 21.5% when adjusted for the regression dilution bias.
When adjusted for standard risk factors, the hazard ratio of MI
in men with high anger-out score was 1.64 (p = 0.007). When
psychological risk factors were combined, the risks were
HR = 2.26 [1.26, 4.06] and HR = 2.72 [1.23, 6.01] for alterna-
tive indices. The risk of stroke was not associated with any
psychological risk factors. CONCLUSION: Individual psycho-
logical risk factors were found to be of limited signiﬁcance in
cardiovascular risk prediction. Composite indices of psychologi-
cal outcomes were signiﬁcantly associated with the increased risk
of MI; such measures of psychological risk could be considered in
risk equations.
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OBJECTIVE: Major risk factors for Stroke are well known and
are relatively easy to assess in community screens. However, less
than one-third of all persons found to have modiﬁable risk
factors follow–up with a primary care physician up to six months
post screening. This study tested the effectiveness of a patient
counselor intervention to enhance motivation and reduce barri-
ers in seeking medical advice regarding screen-detected sroke
risk. METHODS: A total of 227 patients identiﬁed as having risk
of Stroke were randomly allocated either to an experimental
group that received a telephonic intervention (patient counselor)
or a telephonic intervention plus physician notiﬁcation of study
results or were assigned to a control group that received usual
care (advice only) and were followed for six months. Follow-up
data was collected at three months post screening visit.
RESULTS: MD visits after screening date had increased signiﬁ-
cantly in intervention group compared to control group from
baseline levels (70.1% versus 52.9%, p-value < 0.05). We further
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